At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SI Shoulder Innovations, Inc.
Market Closed 06-26 16:00:00 EDT
22.79
+1.18
+5.46%
盘后19.80
-2.99-13.12%
17:57 EDT
High22.92Low20.91Vol766.96K
Open21.52D1 Closing21.61Amplitude9.31%
Mkt Cap472.39MTradable Cap113.95MTotal Shares20.73M
T/O17.30MT/O Rate15.34%Tradable Shares5.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Shoulder Innovations Shareholders Ratify Deloitte as Auditor for 2026
Reuters  ·  04:10
Shoulder Innovations Shareholders Ratify Deloitte as Auditor for 2026
Shoulder Innovations COO Matthew Fraser Ahearn sells USD 373,787 of common shares
Reuters  ·  06-17
Shoulder Innovations COO Matthew Fraser Ahearn sells USD 373,787 of common shares
BUZZ-U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner
Reuters  ·  06-11
BUZZ-U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner
Gold, silver slide as rate risk overwhelms haven demand - Kitco PM Report
Kitco  ·  06-09
Gold, silver slide as rate risk overwhelms haven demand - Kitco PM Report
Insider Move: SI-Bone Director’s Latest Stock Sale Raises Eyebrows
TIPRANKS  ·  06-09
Insider Move: SI-Bone Director’s Latest Stock Sale Raises Eyebrows
SI-BONE Shareholders Endorse Governance and Lease Amendment
TIPRANKS  ·  06-09
SI-BONE Shareholders Endorse Governance and Lease Amendment
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
GlobeNewswire  ·  06-05
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
Analyst Reaffirms Buy on SI-Bone, Keeps $27 Price Target Amid Confidence in Growth and Profitability Outlook
TIPRANKS  ·  06-03
Analyst Reaffirms Buy on SI-Bone, Keeps $27 Price Target Amid Confidence in Growth and Profitability Outlook
Insider Move at SI-Bone: Director’s Stock Sale Turns Heads on Wall Street
TIPRANKS  ·  06-02
Insider Move at SI-Bone: Director’s Stock Sale Turns Heads on Wall Street
Shoulder Innovations management to attend Goldman Sachs Global Healthcare Conference
Reuters  ·  05-27
Shoulder Innovations management to attend Goldman Sachs Global Healthcare Conference
SI-Bone management to meet with Needham
TIPRANKS  ·  05-27
SI-Bone management to meet with Needham
Top SI-Bone Executives Quietly Unload Shares in Coordinated Insider Move
TIPRANKS  ·  05-21
Top SI-Bone Executives Quietly Unload Shares in Coordinated Insider Move
Shoulder Innovations (SI) Q1 Losses Deepen And Test Premium Growth Narrative
Simply Wall St.  ·  05-15
Shoulder Innovations (SI) Q1 Losses Deepen And Test Premium Growth Narrative
Analysts Offer Insights on Healthcare Companies: Shoulder Innovations, Inc. (SI), Maze Therapeutics, Inc. (MAZE) and PACS Group Inc (PACS)
TIPRANKS  ·  05-14
Analysts Offer Insights on Healthcare Companies: Shoulder Innovations, Inc. (SI), Maze Therapeutics, Inc. (MAZE) and PACS Group Inc (PACS)
BIOKIN's SI-B036 Bispecific Antibody Injection Receives Clinical Trial Approval for Advanced Solid Tumors
Stock News  ·  05-14
BIOKIN's SI-B036 Bispecific Antibody Injection Receives Clinical Trial Approval for Advanced Solid Tumors
Shoulder Innovations Reports First Quarter 2026 Financial Results And Raises Full Year Outlook
Reuters  ·  05-14
Shoulder Innovations Reports First Quarter 2026 Financial Results And Raises Full Year Outlook
Shoulder Innovations Inc reports results for the quarter ended March 31 - Earnings Summary
Reuters  ·  05-14
Shoulder Innovations Inc reports results for the quarter ended March 31 - Earnings Summary
Shoulder Innovations Q1 EPS $(0.41) Misses $(0.40) Estimate, Sales $16.708M Beat $14.536M Estimate
Benzinga  ·  05-14
Shoulder Innovations Q1 EPS $(0.41) Misses $(0.40) Estimate, Sales $16.708M Beat $14.536M Estimate
Shoulder Innovations Q1 operating loss widens to $8.98 million; revenue rises 65% to $16.7 million
Reuters  ·  05-14
Shoulder Innovations Q1 operating loss widens to $8.98 million; revenue rises 65% to $16.7 million
Shoulder Innovations: Expects Net Revenue for the Full Year 2026 to Be in the Range of $65 Million to $68 Million
THOMSON REUTERS  ·  05-14
Shoulder Innovations: Expects Net Revenue for the Full Year 2026 to Be in the Range of $65 Million to $68 Million

Introduction

Company Name.
Shoulder Innovations, Inc.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Issue price:
--